Amid reports of H9N2 cases and clusters of respiratory illnesses affecting children in northern China, the Union Health Ministry in India has been actively monitoring the situation. However, reassuringly, the ministry has conveyed that the risk to India from these occurrences remains low.
The World Health Organization (WHO) has acknowledged the clustering of respiratory illnesses in Chinese children. Yet, investigations haven’t identified any unusual pathogen or unexpected clinical signs linked to these incidents. While an increase in respiratory diseases in China has been reported recently, the causes are attributed to common factors associated with childhood respiratory illnesses.
Specifically addressing the concerns related to avian influenza, a recent meeting chaired by the Director-General of Health Services (DGHS) discussed preparedness measures against the backdrop of a human case of H9N2 reported in China. According to the WHO’s overall risk assessment, the probability of human-to-human spread and the case fatality rate among reported H9N2 cases remain low.
“India is prepared for any kind of exigency that may emerge from the current situation,” a health ministry statement read.
Embracing a comprehensive One Health approach, the nation is adopting an integrated roadmap to address such critical health issues. Notably, India has significantly fortified its health infrastructure, especially in the aftermath of the COVID-19 pandemic.
Under the PM-Ayushman Bharat Health Infrastructure Mission (PM-ABHIM), the country has launched a robust initiative aimed at enhancing the capacities of health systems and institutions across all levels of care. This strategic move aims to fortify the health systems to effectively respond to current and future pandemics and disasters.
Additionally, India’s surveillance and detection networks, such as the Integrated Disease Surveillance Programme (IDSP), boast extensive experience in managing challenging health crises, as evidenced during the COVID-19 pandemic.